A pregnant patient diagnosed with preeclampsia with severe features shows an increased risk of developing HELLP syndrome. Which nursing intervention is most appropriate to prioritize for this patient?

A) Administer magnesium sulfate to prevent seizures

B) Encourage increased oral fluid intake to manage oligohydramnios

C) Monitor fetal heart rate and uterine activity continuously

D) Advise bed rest to improve placental perfusion

A 30-year-old pregnant patient at 32 weeks of gestation presents with preeclampsia with severe features. Her laboratory results show significant proteinuria, elevated liver enzymes, and thrombocytopenia. Ultrasound findings indicate oligohydramnios and increased resistance in uterine arteries. Based on these findings, which nursing intervention should be prioritized to prevent complications for both mother and fetus?

A) Initiate magnesium sulfate therapy to prevent seizures.

B) Administer corticosteroids to enhance fetal lung maturity.

C) Encourage increased fluid intake to improve amniotic fluid volume.

D) Schedule daily non-stress tests to monitor fetal well-being.

A pregnant patient with worsening preeclampsia has developed symptoms indicative of HELLP syndrome, including elevated liver enzymes and low platelet count. The healthcare team is considering immediate delivery due to recurrent fetal late decelerations. What is the priority nursing action to prepare for the potential emergency delivery?

A) Administer a bolus of magnesium sulfate as ordered.

B) Initiate a continuous infusion of oxytocin to induce labor.

C) Ensure the availability of blood products for transfusion.

D) Position the patient in a left lateral position to improve placental perfusion.

A nurse is caring for a patient with preeclampsia whose condition is rapidly progressing towards HELLP syndrome. The patient reports a severe headache, visual disturbances, and right upper quadrant pain. Her blood pressure is 170/110 mmHg, and fetal monitoring shows late decelerations. What should be the nurse's priority intervention?

C) Prepare the patient for an emergency cesarean delivery.

A) Administer a bolus of IV magnesium sulfate as ordered.

B) Increase the rate of the antihypertensive drip.

C) Prepare the patient for an emergency cesarean delivery.

D) Reassess the fetal heart rate in 15 minutes.

A patient with severe preeclampsia has been started on a magnesium sulfate infusion. Which clinical finding should prompt the nurse to immediately notify the healthcare provider?

B) Respiratory rate of 10 breaths per minute

A) Presence of deep tendon reflexes

B) Respiratory rate of 10 breaths per minute

C) Urine output of 40 mL per hour

D) Blood pressure of 150/90 mmHg

A pregnant patient with severe preeclampsia and progressing HELLP syndrome is being prepared for an expedited cesarean section. The nurse is monitoring the patient who is currently receiving a magnesium sulfate infusion. Which clinical sign would prompt the nurse to suspect magnesium toxicity and immediately alert the healthcare provider?

B) Respiratory rate of 10 breaths per minute

A) Blood pressure of 160/100 mmHg

B) Respiratory rate of 10 breaths per minute

C) Hyperreflexia in deep tendon reflexes

A nurse is caring for a patient with severe preeclampsia who is undergoing a cesarean section under general anesthesia. The patient's coagulation profile shows a prolonged PT and elevated INR. What is the priority nursing action immediately following the administration of fresh frozen plasma (FFP)?

C) Evaluate the patient's coagulation profile.

A) Monitor the patient's blood pressure closely.

B) Assess the patient's respiratory status.

C) Evaluate the patient's coagulation profile.

D) Check the patient's urine output.

A nurse is caring for a patient with severe preeclampsia who is undergoing a cesarean section under general anesthesia. The patient has a prolonged prothrombin time (PT) and an elevated INR. Which of the following actions should the nurse prioritize in the immediate postoperative period?

A) Monitor the patient's neurological status and respiratory function closely.

B) Administer additional magnesium sulfate to prevent seizures.

C) Encourage early ambulation to prevent deep vein thrombosis.

D) Increase fluid intake to promote diuresis and reduce edema.

A postpartum patient with a history of severe preeclampsia is exhibiting signs of respiratory distress and potential magnesium toxicity. Which of the following interventions should the nurse prioritize to address the patient's current clinical status?

B) Administer a prescribed dose of calcium gluconate.

A) Increase the rate of oxygen delivery via nasal cannula.

B) Administer a prescribed dose of calcium gluconate.

C) Prepare the patient for an immediate CT scan to rule out other causes of respiratory distress.

D) Initiate continuous blood pressure monitoring to adjust antihypertensive medication.

A patient in the immediate postoperative period presents with respiratory distress, diminished breath sounds bilaterally, and somnolence after receiving magnesium sulfate for preeclampsia. Which intervention should the nurse prioritize to address the patient's respiratory status?

C) Administer calcium gluconate to reverse magnesium toxicity.

A) Increase the oxygen flow rate to 6 liters per minute.

B) Prepare for endotracheal intubation and mechanical ventilation.

C) Administer calcium gluconate to reverse magnesium toxicity.

D) Position the patient in a semi-Fowler's position to facilitate breathing.

preeclampsia - Nursing Case Study

Pathophysiology

• Primary mechanism: Abnormal placentation leads to impaired remodeling of the spiral arteries, resulting in reduced blood flow to the placenta and subsequent placental ischemia. This triggers the release of antiangiogenic factors into the maternal circulation, contributing to endothelial dysfunction.

• Secondary mechanism: The endothelial dysfunction causes widespread vasoconstriction and increased vascular permeability, leading to hypertension and proteinuria. The imbalance between vasoconstrictors and vasodilators exacerbates these symptoms.

• Key complication: The resulting systemic endothelial injury can progress to multi-organ dysfunction, particularly affecting the liver, kidneys, and brain, manifesting as eclampsia, HELLP syndrome, or other severe maternal complications.

Patient Profile

Demographics:

32-year-old female, teacher

History:

• Key past medical history: Gestational hypertension in previous pregnancy

• Current medications: Prenatal vitamins, low-dose aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent headache and visual disturbances

• Key symptoms: Swelling in hands and feet, upper abdominal pain, nausea

• Vital signs: Blood pressure 150/100 mmHg, heart rate 95 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F

Section 1

New Diagnostic Results:

Following the initial presentation, the patient underwent laboratory investigations to further assess the severity of her condition. Her urine analysis revealed significant proteinuria, with a protein-to-creatinine ratio of 0.8, confirming the diagnosis of preeclampsia with severe features. Additionally, her liver function tests showed elevated liver enzymes, specifically AST at 75 U/L and ALT at 80 U/L, indicating potential involvement of the liver. A complete blood count was performed, revealing a slight thrombocytopenia with a platelet count of 110,000/μL, raising concerns about the progression towards HELLP syndrome.

Ultrasound imaging was conducted to evaluate fetal well-being and placental function. The ultrasound showed evidence of oligohydramnios, with an amniotic fluid index of 5 cm, suggesting decreased placental perfusion. Doppler studies revealed increased resistance in the uterine arteries, consistent with impaired placental blood flow. These findings suggested that the fetus might be experiencing intrauterine growth restriction, which is a common complication in severe preeclampsia due to compromised placental function.

These diagnostic results provide crucial information about the patient's condition and guide the clinical team in planning further management. The presence of proteinuria, elevated liver enzymes, and thrombocytopenia indicates a risk of worsening maternal condition and potential for HELLP syndrome development. The ultrasound findings necessitate close monitoring of the fetus, with consideration for early delivery if maternal or fetal status deteriorates. The healthcare team must weigh the risks and benefits of immediate intervention versus continued monitoring, keeping in mind the gestational age and the potential for rapid progression of complications.

Section 2

Change in Patient Status:

The patient's condition began to evolve rapidly over the next 24 hours. She reported a persistent headache and visual disturbances, such as seeing spots, which suggested worsening cerebral symptoms associated with preeclampsia. On examination, her blood pressure was markedly elevated at 170/110 mmHg, despite being on antihypertensive medication. This elevated blood pressure posed an increased risk for cerebrovascular complications, necessitating immediate intervention to prevent seizures or stroke.

In addition to the neurological symptoms, the patient exhibited right upper quadrant abdominal pain, an indication of potential liver capsule distension due to hepatic involvement. Repeat laboratory tests showed further deterioration with liver enzymes escalating—AST at 120 U/L and ALT at 130 U/L—and a further drop in platelet count to 95,000/μL. These changes confirmed the progression towards HELLP syndrome, a severe form of preeclampsia that could lead to serious maternal and fetal complications if not promptly addressed.

The fetal status was also concerning. Continuous fetal monitoring indicated recurrent late decelerations in the heart rate pattern, a sign of fetal distress likely due to compromised placental function. Given these developments, the healthcare team held an urgent multidisciplinary meeting to discuss the potential benefits of immediate delivery versus continued monitoring. The decision-making process needed to carefully balance the risks of preterm delivery against the escalating maternal and fetal risks associated with waiting longer. The team prepared for potential emergency delivery, with all necessary precautions in place to manage both maternal and neonatal outcomes effectively.

Section 3

As the multidisciplinary team deliberated, the patient's condition continued to evolve, necessitating swift clinical reasoning and intervention. During the ongoing monitoring, the patient's neurological symptoms worsened; she became increasingly agitated and confused. Her deep tendon reflexes were hyperactive, an ominous sign suggesting the imminent risk of eclampsia. In response to these neurological changes, the healthcare team initiated a magnesium sulfate infusion to prevent seizures, carefully monitoring for signs of magnesium toxicity, such as respiratory depression and loss of reflexes.

Simultaneously, repeat laboratory tests revealed further deterioration in her condition. Her platelet count had dropped to 80,000/μL, and her liver function tests showed a significant increase, with AST and ALT now elevated to 150 U/L and 160 U/L, respectively. These findings confirmed the progression of HELLP syndrome. Additionally, her LDH levels rose to 700 U/L, suggesting hemolysis. The patient's renal function was also compromised, with serum creatinine increasing to 1.5 mg/dL, indicating worsening renal involvement.

In light of these developments, the decision was made to proceed with an expedited delivery to mitigate the risks to both mother and fetus. The team prepared for a cesarean section, given the fetal distress indicated by persistent late decelerations and declining biophysical profile scores. The obstetric, anesthesiology, and neonatal teams coordinated closely to ensure all necessary preparations for delivery and immediate postnatal care, focusing on minimizing potential complications for the newborn while stabilizing the mother's condition. This decision underscored the balance between maternal and fetal risks, highlighting the critical need for rapid, evidence-based interventions in managing severe preeclampsia and its complications.

Section 4

Following the decision to proceed with a cesarean section, the multidisciplinary team acted swiftly to stabilize the patient for surgery. Despite the administration of magnesium sulfate, the patient exhibited increasing respiratory rates, rising to 28 breaths per minute, and her oxygen saturation dropped to 92% on room air, prompting the initiation of supplemental oxygen. Her blood pressure remained elevated at 160/110 mmHg, with a heart rate of 110 beats per minute. The team noted the importance of closely monitoring for signs of magnesium toxicity, as well as ensuring adequate respiratory support and blood pressure management before and during the procedure.

As the surgical team prepared for delivery, new diagnostic results indicated further complications. The patient's coagulation profile revealed a prolonged prothrombin time (PT) of 18 seconds and an international normalized ratio (INR) of 1.8, raising concerns about her ability to adequately clot during surgery. This necessitated the administration of fresh frozen plasma to reduce the risk of excessive bleeding. Concurrently, fetal monitoring showed persistent late decelerations, reinforcing the urgency of delivering the baby to prevent further compromise.

In response to these developments, the anesthesiology team opted for general anesthesia, given the coagulation abnormalities and the patient's altered mental status. The cesarean section was carried out with heightened vigilance, ensuring rapid intervention for any emergent complications. Post-operatively, the mother was transferred to the intensive care unit for close monitoring, particularly of her neurological status and respiratory function, while the neonatal team focused on assessing the newborn's condition, ready to address any immediate needs. This phase of the case highlights the critical interplay between swift clinical decision-making and the application of evidence-based interventions to address evolving complications in severe preeclampsia.

Section 5

In the immediate postoperative period, the patient exhibited further changes in her clinical status, necessitating continued vigilance and adaptive management strategies. Despite the provision of supplemental oxygen, the patient’s respiratory status showed minimal improvement, with her respiratory rate remaining elevated at 26 breaths per minute and oxygen saturation stabilizing at 94% with 4 liters of oxygen via nasal cannula. Her breath sounds were noted to be diminished bilaterally upon auscultation, raising concerns about potential pulmonary edema, a known complication of both preeclampsia and magnesium sulfate administration. Consequently, a chest X-ray was ordered to evaluate the extent of any pulmonary involvement.

Simultaneously, the patient’s neurological assessment revealed increased somnolence and diminished deep tendon reflexes, indicating a possible escalation towards magnesium toxicity. Her serum magnesium level was measured at 6.5 mg/dL, confirming the need to adjust the magnesium sulfate infusion. The clinical team swiftly administered calcium gluconate as an antidote to counteract the magnesium’s effects and adjusted the magnesium infusion rate while closely monitoring her neurological status. Meanwhile, the patient’s blood pressure remained a challenge, with readings persisting at hypertensive levels, necessitating the introduction of a continuous intravenous antihypertensive medication to achieve greater control.

These developments underscored the importance of dynamic and integrated clinical reasoning, as the team continued to balance the management of preeclampsia complications with the need to address emergent respiratory and neurological concerns. The unfolding scenario required ongoing assessment of the patient’s response to interventions, anticipating potential new complications, and preparing contingency plans for rapid intervention, ensuring both maternal and neonatal safety during this critical phase. This phase sets the stage for the next steps in her recovery, where stabilizing her condition and preventing further complications will be central to the care plan.